Indicators

Markets:

News

Latest News about LLY

Recent news which mentions LLY

...

26 27 28 29 30 31 32 33 Next >

Investors Like Certainty. Trump's Win Gave Them Some.

November 08, 2024

Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock.

November 08, 2024

Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware

November 07, 2024

Market Whales and Their Recent Bets on LLY Options

November 07, 2024

Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?

November 06, 2024

Missed Out on Eli Lilly? Buy This Amazing Growth Stock Instead

November 06, 2024

10 Health Care Stocks Whale Activity In Today's Session

November 05, 2024

Assessing Eli Lilly's Performance Against Competitors In Pharmaceuticals Industry

November 05, 2024

Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential

November 04, 2024

What's Going On With Hims & Hers Health Stock Monday?

November 04, 2024

As Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%

November 04, 2024

Could This Near Trillion-Dollar Stock Be a Millionaire Maker?

November 03, 2024

Market Volatility Soars Ahead Of Elections, Tech Earnings Mixed, Strikes And Hurricanes Knock Employment Down: This Week In The Markets

November 01, 2024

Popular Weight Loss Drug Wegovy Shows Encouraging Results in Liver Fibrosis Trial

November 01, 2024

Why Eli Lilly Is a No-Brainer Stock to Buy on the Dip

November 01, 2024

Nasdaq Tumbles Over 100 Points Ahead Of Big Tech Earnings: Fear & Greed Index Remains In 'Greed' Zone

October 31, 2024

Are Eli Lilly's Lowered Expectations a Reason to Sell?

October 31, 2024

AMD Earnings Show Power Of Nvidia Software, ADP Data Defies Expectations

October 30, 2024

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights

October 30, 2024

Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast

October 30, 2024

Eli Lilly (LLY) Q3 2024 Earnings Call Transcript

October 30, 2024

Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday?

October 30, 2024

Why Eli Lilly Stock Is Sinking Today

October 30, 2024

O-I Glass Posts Downbeat Results, Joins AMD, Qorvo And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

October 30, 2024

Eli Lilly Q3 Earnings: Mounjaro Sales More Than Double, Takes $2.98 Billion Hit To Profit, Cuts Annual Outlook, Stock Tanks

October 30, 2024

Zepbound, Mounjaro Maker Eli Lilly Climbs In Wednesday Pre-Market As Impressive 51% YTD Gain Sparks Stock Split Speculation

October 30, 2024

A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years

October 30, 2024

Is Eli Lilly Stock a Buy?

October 30, 2024

Eli Lilly Says New Data Can Potentially Provide Path To Improved Donanemab Profile By Lower Risk Of Imaging Abnormalities In Patients With Early Alzheimer's

October 29, 2024

Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains

October 29, 2024

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.